AGILON HEALTH INC (AGL)
US00857U1079 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 107.57M | 497.10M | 1.04B | 106.80M | 123.60M | |||
| Marketable Securities | 380.77M | 411.90M | N/A | N/A | N/A | |||
| Receivables | 942.46M | 497.60M | 293.40M | 144.60M | 93.30M | |||
| Other Current Assets | 49.27M | 44.70M | 33.80M | 42.80M | 28.60M | |||
| Total Current Assets | 1.48B | 1.45B | 1.37B | 294.20M | 245.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 40.99M | 33.10M | 20.90M | 16.00M | 18.80M | |||
| Investments And Advances | 44.75M | 17.40M | 6.70M | N/A | N/A | |||
| Goodwill | 24.13M | 41.50M | 41.50M | 41.50M | 41.50M | |||
| Intangibles | 63.77M | 67.70M | 55.40M | 60.50M | 71.10M | |||
| Other Non-Current Assets | 87.15M | 86.50M | 94.50M | 34.10M | 25.70M | |||
| Total Non-Current Assets | 260.79M | 246.20M | 219.10M | 152.20M | 157.30M | |||
| TOTAL ASSETS | 1.74B | 1.70B | 1.59B | 446.40M | 402.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 6.25M | 5.00M | 5.00M | 3.00M | 3.00M | |||
| Accounts Payable | 233.18M | 183.40M | 112.90M | 97.20M | 67.60M | |||
| Other Current Liabilities | 737.72M | 346.70M | 239.00M | 166.60M | 129.00M | |||
| Total Current Liabilities | 977.16M | 535.10M | 357.00M | 266.80M | 199.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 32.31M | 38.50M | 43.40M | 64.70M | 67.10M | |||
| Other Non-Current Liabilities | 70.38M | 83.30M | 94.30M | 90.10M | 87.10M | |||
| Total Non-Current Liabilities | 101.87M | 121.10M | 137.40M | 154.80M | 154.20M | |||
| TOTAL LIABILITIES | 1.08B | 656.20M | 494.40M | 421.60M | 353.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.33B | -1.06B | -957.70M | -551.20M | -491.10M | |||
| Additional Paid In Capital | 1.99B | 2.11B | 2.05B | 264.00M | 256.60M | |||
| Minority Interest | -611.00K | -300.00K | 0.00 | N/A | N/A | |||
| Common Shares | 4.06M | 4.10M | 4.00M | 312.00M | 283.50M | |||
| Other Shareholders' Equity | -2.30M | -5.60M | N/A | N/A | N/A | |||
| Shares Outstanding | 406.39M | 412.40M | 400.10M | 384.00M | 384.00M | |||
| Tangible Book Value per Share | 1.41 | 2.26 | 2.49 | -0.20 | -0.17 | |||
| Total Shareholders' Equity | 661.84M | 1.04B | 1.09B | 24.80M | 49.00M | |||
| TOTAL LIABILITIES AND EQUITY | 1.74B | 1.70B | 1.59B | 446.40M | 402.80M | |||
| Statistics | ||||||||
| Debt/Equity | 0.05 | 0.04 | 0.04 | 2.61 | 1.37 | |||
| Current Ratio | 1.51 | 2.71 | 3.83 | 1.10 | 1.23 | |||
| Return On Assets (ROA) | -15.08% | -6.28% | -25.63% | -13.46% | -70.16% | |||
| Return On Equity (ROE) | -39.68% | -10.24% | -37.23% | -242.34% | -576.73% | |||
All data in USD